GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Explores Telehealth-Adapted Family-Based Treatment for Eating Disorders in Rural Youth

by GOAI
Share To

A recent study published in the *Journal of Eating Disorders* examines how adaptations to Family-Based Treatment for Primary Care (FBT-PC) can address restrictive eating disorders in children and adolescents, particularly in rural areas. Researchers focused on modifying this evidence-based therapy to better suit regions where access to specialized mental health care is limited. The findings highlight the potential of these adaptations to improve treatment outcomes for young individuals facing eating disorders in underserved communities.

The study emphasizes the challenges faced by families in rural settings, where geographic isolation and a shortage of trained professionals often hinder access to effective care. By tailoring FBT-PC—a widely recognized approach that involves parents taking an active role in their child’s recovery—to meet the unique needs of these populations, researchers aim to make treatment more accessible and practical. The research outlines specific modifications, such as integrating telehealth services and simplifying therapeutic techniques, which could help bridge gaps in care delivery. This approach seeks to empower families while addressing barriers posed by location and resource availability.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top